01 7Iressa
02 2Iressa
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 268
2019 Revenue in Millions : 423
Growth (%) : -37
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 183
2020 Revenue in Millions : 268
Growth (%) : -32
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 114
2021 Revenue in Millions : 183
Growth (%) : -38
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 623
2014 Revenue in Millions : 543
Growth (%) : -13%
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 528
2016 Revenue in Millions : 513
Growth (%) : 3
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : -3.70%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 518
2017 Revenue in Millions : 528
Growth (%) : -2%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 513
2015 Revenue in Millions : 543
Growth (%) : -6
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 423
2018 Revenue in Millions : 518
Growth (%) : -18
LOOKING FOR A SUPPLIER?